Please try another search
For the fiscal year ended 31 December 2021, HLB Science Inc revenues was not reported. Net loss increased 16% to W5.05B. Higher net loss reflects Development Costs increase of 19% to W2.78B (expense), Commission Paid increase from W169.1M to W435.5M (expense), Interest Expense increase from W86.1M to W251.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -W398.65 to -W462.78.
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Operating Income | -4840.7 | -4331.94 | -2629.55 | -1115.52 |
Net Income | -5051.96 | -4351.88 | -2546.67 | -1114.39 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 7472.16 | 3466.78 | 6791.35 | 1188.19 |
Total Liabilities | 9302.62 | 1045.94 | 580.51 | 154.09 |
Total Equity | -1830.46 | 2420.83 | 6210.84 | 1034.1 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | -4283.94 | -4233.69 | -2190.53 | -1091.86 |
Cash From Investing Activities | -5261.62 | 5308.34 | -5702.32 | -248.61 |
Cash From Financing Activities | 8669.66 | 1000 | 7664.84 | 495.55 |
Net Change in Cash | -875.9 | 2074.65 | -228.01 | -844.92 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review